Victor Huber

Victor Huber

Associate Professor

BASIC BIOMEDICAL SCIENCES

Lee Medicine & Science Hall 367

Phone: (605) 658-6390

Email: Victor.Huber@usd.edu

Website: http://people.usd.edu/~Victor.Huber/

Bio:

Evaluation of contributions of vaccination toward prevention of primary influenza virus infections and secondary bacterial super-infections.


Teaching Interests:

Immunology, virology


Research Interests:

Vaccines, influenza virus, Fc receptors, antibodies, cytokines, Streptococcus pyogenes


Education:

  • Department of Infectious Disease, St Jude Children's Research Hospital, 2008
  • Division of Molecular Medicine, Wadsworth Center of the New York State DOH, 2003
  • Ph D, Medical College of Ohio, 2001
  • BS, Northern State University, 1997

Grants:

  • Production of therapeutic human polyclonal antibodies against influenza viruses, NIH. Grant Role: Co-Principal. (2016 - 2018)
  • Identifying and testing CMA-targeting peptides for depleting CryABR120G protein levels., USD-SSOM-PQCD. Grant Role: Co-Principal. (2016 - 2016)
  • A candidate swine influenza virus vaccine: in vivo evaluation of novel chimeric hemagglutinins expressed by parainfluenza virus 5 (PIV5) vector. Grant Role: Principal. (2015 - 2016)
  • Using the Ferret Model of Influenza to Study the Efficacy of SAB-100, BioSNTR/SD EPSCoR. Grant Role: Principal. (2015 - 2016)
  • Role of influenza-induced prothrombosis in Streptococcus pyogenes superinfections, NIH. Grant Role: Supporting. (2012 - 2015)
  • Rapid and Inexpensive Evaluation of Antibody Efficacy with Custom-Designed Fluorescent Nanoparticles, University of South Dakota. Grant Role: Co-Principal. (2012 - 2013)
  • Rapid and Inexpensive Evaluation of Antibody Efficacy with Custom-Designed Fluorescent Nanoparticles, University of South Dakota. Grant Role: Co-Principal. (2012 - 2013)
  • Contribution of influenza virus PB1-F2 toward super-infection with Streptococcus pyogenes, Office of Research and Sponsored Programs-Inside TRACK Grant Program. Grant Role: Principal. (2011 - 2012)
  • Creation of a swine reverse genetics influenza virus system for evaluation of viral bacterial pathogenesis, SSOM Research Committee. Grant Role: Principal. (2011 - 2012)
  • Flu vaccination events, SD Dept of Health/Public Health Preparedness and Response (DHHS). Grant Role: Principal.
  • Construct novel influenza A (H1N1) virus chimeric genes for development of broadly protective vaccine candidates, NIH/NIAID (USDHHS). Grant Role: Co-Principal.
  • Influenza virus-induced alterations of host cells that promote invasive disease with S. pyogenes, USD Office of Research and Sponsored Programs. Grant Role: Principal.

Publications:

Citations listed below are presented in a standardized, modified format for display purposes only. They do not necessarily reflect the preferred style and conventions of the faculty member or discipline.

  • Shepardson, Kelly M., Kyle, Larson, Rachelle, Morton V., Justin, Prigge R., Edward, Schmidt E., Huber, Victor, and Rynda-Apple, Agnieszka. Differential Type I Interferon Signaling Is a Master Regulator of Susceptibility to Postinfluenza Bacterial Superinfection. mBio, 2016.
  • Herrera, Andrea L., Huber, Victor, and Chaussee, Michael S.. The Association between Invasive Group A Streptococcal Diseases and Viral Respiratory Tract Infections, 342. Vol. 7. Front Microbiol, 2016.
  • Huber, Victor, and Vogt, H. B.. So You Want to Be an Author: A Primer on Writing for Publication in the Medical Literature, Part I: Manuscript Preparation. SD Med, 2016.
  • Huber, Victor, and Vogt, H. B.. So You Want to Be an Author: A Primer on Writing for Publication in the Medical Literature, Part II: Manuscript Submission. SD Med, 2016.
  • McCormick, Kara, Jiang, Zhiyong, Zhu, Longchao, Lawson, Steven R., Langenhorst, Robert, Ransburgh, Russell, Brunick, Colin, Tracy, Miranda C., Hurtig, Heather R., Mabee, Leah M., Mingo, Mark, Li, Yanhua, Webby, Richard, Huber, Victor, and Fang, Ying. Construction and immunogenicity evaluation of recombinant influenza A viruses containing chimeric hemagglutinin genes derived from genetically divergent influenza A H1N1 subtype viruses., e0127649. Vol. 10. PLoS ONE, 2015.
  • Klonoski, J M., Hurtig, H R., Juber, B A., Schuneman, M J., Bickett, T E., Svendsen, J M., Burum, B, Penfound, T A., Sereda, Grigoriy, Dale, J B., Chaussee, Michael, and Huber, Victor. Vaccination against the M protein of Streptococcus pyogenes prevents death after influenza virus: S. pyogenes super-infection., 5241-9. Vol. 32, Iss. 40. Vaccine, 2014. (DOI: 10.1016/j.vaccine.2014.06.093)
  • Klonoski, Joshua M., Sandbulte, Heather R., Juber, Brian A., Schuneman, Margaret J., Bickett, Thomas E., Svendsen, Joshua M., Burum, Brandon, Penfound, Thomas A., Sereda, Grigoriy, Dale, James B., Chaussee, Michael S., and Huber, Victor. Vaccination against the M protein of Streptococcus pyogenes prevents death after influenza virus:S. pyogenes super-infection, 5241-9. Vol. 32. Vaccine, 2014.
  • Huber, Victor. Influenza Vaccines: From whole virus preparations to recombinant protein technology, 31-42. Vol. 13. Expert Review of Vaccines, 2014.
  • Sun, Zhi, Lawson, Steven, Langenhorst, Robert, McCormick, Kara L., Brunick, Colin, Opriessnig, Tanja, Baker, Rodney, Yoon, Kyoung-Jin, Zhang, Weipang, Huber, Victor, and Fang, Ying. Construction and immunogenicity evaluation of an epitope-based antigen against swine influenza A virus using Escherichia coli heat-labile toxin B subunit as a carrier-adjuvant, 229-38. Vol. 164. Veterinary Microbiology, 2013.
  • McKenzie, Casey, Klonoski, Joshua, Maier, Taylor, Trujillo, Glenda, Vitiello, Peter F., Huber, Victor, and Lee, Lance. Enhanced response to pulmonary Streptococcus pneumoniae infection is associated with primary ciliary dyskinesia in mice lacking Pcdp1 and Spef2. Vol. 2, Iss. 18. Cilia, 2013.
  • Henneman, Kayla, Huber, Victor, and Van Peursem, Dan. Mathematical modeling of influenza and secondary bacterial infection. WSEAS Transactions on Biology and Biomedicine, 2013.
  • Henneman, Kayla, Van Peursem, Dan, and Huber, Victor. Mathematical modeling of influenza and a secondary bacterial infection. Edited by Professor Ka-Lok Ng, 1-11. Vol. 10, Iss. 1. Transactions on Biology and Biomedicine / WSEAS, 2013.
  • Huber, Victor. Can surveillance of the influenza virus PB1-F2 gene be used to predict the severity of secondary bacterial infections?. Edited by Letter from Editor attached, 523-4. Vol. 3. Virulence, 2012.
  • Sun, Zhi, Huber, Victor, McCormick, Kara, Kaushik, Radhey, Boon, Adrianus C., Zhu, Longchao, Hause, Ben, Webby, Richard J., and Fang, Ying. Characterization of a porcine intestinal epithelial cell line for influenza virus production, 2008-16. Vol. 93. J Gen Virol, 2012.
  • Cwach, Kevin T., Sandbulte, Heather R., Klonoski, Joshua M., and Huber, Victor. Contribution of murine innate serum inhibitors toward interference within influenza virus immune assays, 127-35. Vol. 6. Influenza Other Respir Vir, 2012.
  • McCullers, Jonathan A., and Huber, Victor. Correlates of vaccine protection from influenza and its complications, 34-44. Vol. 8. Hum Vaccin Immunother, 2012.
  • Weeks-Gorospe, Jenni N., Hurtig, Heather R., Iverson, Amy R., Schuneman, Margaret J., Webby, Richard J., McCullers, Jonathan A., and Huber, Victor. Naturally occurring swine influenza A virus PB1-F2 phenotypes that contribute to super-infection with Gram-positive respiratory pathogens, 9035-43. Vol. 85. J Virol, 2012.
  • Chaussee, Michael, Sandbulte, Heather, Schuneman, Margaret J., DePaula, Frank, Addengast, Leslie, Schlenker, Evelyn, and Huber, Victor. Inactivated and live, attenuated influenza vaccines protect mice against influenza:Streptococcus pyogenes super-infections. Vaccine, 2011.
  • Halasa, Natasha, Englund, Janet A., Nachman, Sharon, Weinberg, Geoffrey A., Huber, Victor, Allison, Kim, Dubovsky, Filip, Yi, Tingting, McCullers, Jonathan A., and Flynn, Patricia M.. Safety of live attenuated influenza vaccine in mild to moderately immunocompromised children with cancer, 4110-5. Vol. 29. Vaccine, 2011.
  • Chaussee, Michael S., Sandbulte, Heather R., Schuneman, Margaret J., DePaula, Frank P., Addengast, Leslie A., Schlenker, Evelyn H., and Huber, Victor. Inactivated and live, attenuated influenza vaccines protect mice against influenza:Streptococcus pyogenes super-infections, 3773-81. Vol. 29. Vaccine, 2011.
  • Huber, Victor, Peltola, Ville, Iverson, Amy, and McCullers, Jonathan A.. Contribution of vaccine-induced immunity toward either the HA or the NA component of influenza viruses limits secondary bacterial complications., 4105-08. Vol. 84. J. Virol, 2010.
  • Huber, Victor, Thomas, Paul, and McCullers, Jonathan. A multi-valent vaccine approach that elicits broad immunity within an influenza subtype., 1192-1200. Iss. 27. Vaccine, 2009.
  • Huber, Victor, and McCullers, Jonathan A.. FluBlok, a recombinant influenza vaccine, 75-85. Vol. 10. Curr Opin Mol Ther, 2008.
  • Huber, Victor, Kleimeyer, Loren, and McCullers, Jonathan A.. Live, attenuated influenza virus (LAIV) vehicles are strong inducers of immunity towarad influenza B virus, 5381-88. Vol. 26. Vaccine, 2008.
  • Huber, Victor, and McCullers, Jonathan A.. Vaccines against pandemic influenza: what can be done before the next pandemic?, S113-S117. Vol. 27. Pediatr Infect Dis, 2008.
  • Huber, Victor, McKeon, Raelene, Brackin, Martha, Miller, Laura, Keating, Rachael, Brown, Scott, Makarova, Natalia, Perez, Daniel, MacDonald, Gene, and McCullers, Jonathan. Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza, 981-90. Vol. 13. Clin Vaccine Immunol, 2006.
  • Huber, Victor, and McCullers, Jonathan. Live attenuated influenza vaccine is safe and immunogenic in immunocompromised ferrets, 677-84. Vol. 193. J Infect Dis, 2006.
  • Huber, Victor, Mondal, Tappan, Factor, Stewart, Seegal, Richard, and Lawrence, David. Serum antibodies from Parkinson's disease patients react with neuronal membrane proteins from a mouse dopaminergic cell line and affect its dopamine expression, 1. Vol. 3. J Neuroinflammation, 2006.
  • McCullers, Jonathan, Hoffman, Erich, Huber, Victor, and Nickerson, Asia. A single amino acid change in the C-terminal domain of the matrix protein M1 of influenza B virus confers mouse adaptation and virulence, 318-26. Vol. 336. Virology, 2005.
  • Hudson, Chad, Mondal, Tappan, Cao, Ling, Kasten-Jolly, Jane, Huber, Victor, and Lawrence, David. The dietary supplement ephedrine induced beta-adrenergic mediated exacerbation of systemic lupus eryhematosus in NZM391 mice, 293-307. Vol. 14. Lupus, 2005.
  • Huber, Victor, Arulanandam, Bernard, Arnaboldi, Paul, Elmore, Monica, Sheehan, Christine, Kallakury, Bhaskar, and Metzger, Dennis. Delivery of IL-12 intranasally leads to reduced IL-12-mediated toxicity, 801-9. Vol. 3. Int Immunoparmacol, 2003.
  • Huber, Victor, Lynch, Joyce, Bucher, Doris, Li, Jianhua, and Metzger, Dennis. FcR-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections, 7381-8. Vol. 166. J Immunol, 2001.

Awards and Honors:

  • Anton J. Schwarz Research Professor in Virology, Sanford School of Medicine, 2015
  • Adjunct Assistant Professor, South Dakota State University, 2012

Presentations:

  • McCormick, Kara, Gau, Tonia, Kuehler, Alex, Fang, Ying, Huber, Victor. Influenza A virus genes that contribute to pathogenesis in SD-PJEC swine cells. Presented at the 33rd Annual Meeting of the American Society for Virology, Fort Collins, CO. (June 2014)
  • Klonoski, Joshua, McCormick, Kara, Brunick, Colin, Kuehler, Alex, Gau, Tonia, Huber, Victor. Influenza virus gene contributions toward outcomes after influenza viru:Streptococcus pyogenes super-infection. Presented at the 33rd Annual Meeting of the American Society for Virology, Fort Collins, CO. (June 2014)
  • Huber, Victor. Influenza A virus:Streptococcus pyogenes super-infection and immunity. Presented at the University of Nebraska-Lincoln (UNL) Biotechnology/Life Sciences Seminar Series, Lincoln, NE. (November 2013)
  • McCormick, Kara, Zhu, Longchao, Jiang, Zhiyong, Lawson, Steven, Langenhorst, Robert J., Ransburgh, Russell, Huber, Victor, Fang, Ying. Construction and immunogenicity evaluation of recombinant influenza A viruses containing chimeric HA genes from genetically divergent influenza H1N1 viruses. Presented at the ASM North Central Branch Meeting, Brookings, SD. (October 2013)
  • McCormick, Kara, Zhu, Longchao, Jiang, Zhiyong, Lawson, Steven, Langenhorst, Robert J., Ransburgh, Russell, Huber, Victor, Fang, Ying. Construction and immunogenicity evaluation of recombinant influenza A viruses containing chimeric HA genes from genetically divergent influenza H1N1 viruses. Presented at the 32nd Annual Meeting of the American Society for Virology, University Park, PA. (July 2013)
  • Tummala, Hemachand, Kumar, Sunny, Mingo, Mark, Brunick, Colin, Huber, Victor. Designing of a Novel Pathogen Mimicking Particulate Delivery System (PMPDS) for Vaccines. Presented at the American Association of Pharmaceutical Sciences Innovation in Biotechnology Award Presentation, San Diego, CA. (May 2013)
  • McCormick, Kara, Huber, Victor. Construction and immunogenicity evaluation of recombinant influenza A viruses containing chimeric HA genes from genetically divergent influenza H1N1 viruses. Presented at the FlySwat, Nebraska City, NE. (March 17, 2013)
  • Sun, Zhi, Lawson, Steve, Langenhorst, Robert, McCormick, Kara, Brunick, Colin, Opriessing, Tanja, Baker, Rodney, Yoon, Kyoung-Jin, Huber, Victor, Fang, Ying. Development of an epitope-based vaccine against swine influenza A virus using a non-toxic enterotoxin as the carrier-adjuvant. Presented at the Conference of Research Workers in Animal Diseases, Chicago, IL. (December 2, 2012)
  • Weeks, Jenni, Hurtig, Heather, Iverson, Amy, Schuneman, Margaret, Webby, Richard, McCullers, Jonathan, Huber, Victor. Contribution of naturally occurring swine influenza A virus PB1-F2 phenotypes toward secondary complications with Gram-positive respiratory pathogens. Presented at the Annual BRIN Meeting, Mitchell, SD. (December 1, 2012)
  • Watson, Trevor, Klonoski, Joshua, Schlenker, Evelyn, Huber, Victor. A time course study of influenza:Streptococcus pyogenes super-infections in a mouse model. Presented at the USD Undergraduate Research Poster Presentation, Vermillion, SD. (August 3, 2012)
  • Bickett, Tom, Klonoski, Joshua, Mottishaw, Wendi, Dale, James, Chaussee, Michael, Sereda, Grigoriy, Huber, Victor. Contribution of vaccine-induced antibodies toward protection against influenza virus:Streptococcus pyogenes super-infection. Presented at the USD Undergraduate Research Poster Presentation, Vermillion, SD. (August 3, 2012)
  • Kuehler, Alex, McCormick, Kara, Gau, Tonia, Huber, Victor. Genetic contributino to influenza virulence in a swine cell line. Presented at the USD Undergraduate Research Poster Presentation, Vermillion, SD. (August 3, 2012)
  • Gau, Tonia, McCormick, Kara, Kuehler, Alex, Huber, Victor. The association between virulence and genetic contributions of influenza virus reassortants in a porcine cell line. Presented at the Sanford Summer Research Symposium, Sioux Falls, SD. (August 2, 2012)
  • Francis, David, Li, Feng, Lin, Jun, Zhao, Mojun, Mateo, Kristina, Huber, Victor. Protection from Enteric and Respiratory Infections by Intranasal Delivery of Antigens Along with E coli Heat Labile Enterotoxin as an Adjuvant. Presented at the The 6th International Veterinary Vaccines and Diagnostics Conference, Cairns Queensland, Australia. (July 29, 2012)
  • Sun, Zhi, Lawson, Steve, Langenhorst, Robert, McCormick, Kara, Brunick, Colin, Opriessing, Tanja, Baker, Rodney, Yoon, Kyoung-Jin, Huber, Victor, Fang, Ying. Development of an epitope-based vaccine against swine influenza A virus using a non-toxic enterotoxin as the carrier-adjuvant. Presented at the 31st Annual Meeting of the American Society for Virology, Madison, WI. (July 21, 2012)
  • Weeks, Jenni, Hurtig, Heather, Iverson, Amy, Schuneman, Margaret, Webby, Richard, McCullers, Jonathan, Huber, Victor. Contribution of naturally occurring swine influenza A virus PB1-F2 phenotypes toward secondary complications with Gram-positive respiratory pathogens. Presented at the Sanford Research/USD Research Symposium, Vermillion, SD. (May 14, 2012)
  • Weeks, Jenni, Hurtig, Heather, Iverson, Amy, Schuneman, Margaret, Webby, Richard, McCullers, Jonathan, Huber, Victor. Contribution of naturally occurring swine influenza A virus PB1-F2 phenotypes toward secondary complications with Gram-positive respiratory pathogens. Presented at the School of Health Sciences Research Conference, Vermillion, SD. (April 26, 2012)
  • Huber, Victor. Vaccination to prevent infleunza virus:S. pyogenes super-infection. Presented at the 2012 Co-infections Meeting, Bolton Landing, NY. (April 16, 2012)
  • McCormick, Kara, Huber, Victor. Construction of Genetic Reassortant Influenza Viruses for Identification of Virulence Factors in Influenza Virus. Presented at the IdeaFest, Vermillion, SD. (April 11, 2012)
  • Klonoski, Joshua, Huber, Victor. Influenza and Strep pyogenes Secondary Infections. Presented at the IdeaFest, Vermillion, SD. (April 11, 2012)
  • Henneman, Kayla, Huber, Victor, Van Peursem, Dan. Mathematical Modeling of Influenza with a Secondary Infection. Presented at the IdeaFest, Vermillion, SD. (April 11, 2012)
  • McCormick, Kara, Sandbulte, Heather, Sun, Zhi, Fang, Ying, Huber, Victor. Construction of genetic reassortant influenza viruses for identification of virulence factors in influenza virus:Streptococcus pyogenes super-infection. Presented at the Nebraska Center for Virology Annual Retreat (FlySwat), Nebraska City, NE. (March 18, 2012)
  • Weeks, Jenni, Hurtig, Heather, Iverson, Amy, Schuneman, Margaret, Webby, Richard, McCullers, Jonathan, Huber, Victor. Contribution of naturally occurring swine influenza A virus PB1-F2 phenotypes toward secondary complications with Gram-positive respiratory pathogens. Presented at the Nebraska Center for Virology Annual Retreat (FlySwat), Nebraska City, NE. (March 18, 2012)
  • Huber, Victor, Klonoski, Joshua. Vaccination to prevent infleuzna virus:Streptococcus pyogenes super-infection. Presented at the Nebraska Center for Virology Annual Retreat (FlySwat), Nebraska City, NE. (March 18, 2012)
  • McCormick, Kara, Sandbulte, Heather, Fang, Ying, Huber, Victor. Construction of genetic reassortant influenza viruses for identification of virulence factors in influenza virus:Streptococcus pyogenes super-infection. Presented at the John H. and Amy Bowles Lawrence Foundation Symposium: Global Frontiers in Vaccine Development, Sanford Health and University of South Dakota, Sioux Falls and Vermillion, SD. (October 7, 2011)
  • Klonoski, Joshua, Cwach, Kevin, Sandbulte, Heather, Huber, Victor. Contribution of murine innate inhibitors toward interference within influenza virus immune assays. Presented at the John H. and Amy Bowles Lawrence Foundation Symposium: Global Frontiers in Vaccine Development, Sanford Health and University of South Dakota, Sioux Falls and Vermillion, SD. (October 7, 2011)
  • Sandbulte, Heather, Weeks, Jenni, McCullers, Jonathan, Huber, Victor. Contribution of naturally occurring influenza viruses toward super-infection with gram-positive respiratory pathogens. Presented at the John H. and Amy Bowles Lawrence Foundation Symposium: Global Frontiers in Vaccine Development, Sanford Health and University of South Dakota, Sioux Falls and Vermillion, SD. (October 7, 2011)
  • Zhao, Mojun, Huber, Victor, Ran, Zhiguang, Li, Feng, Francis, David. Intranasal immunization of an inactivated influenza H1N1 vaccine provides protection from detectable infection by homologous virus challenge in a gnotobiotic pig model. Presented at the John H. and Amy Bowles Lawrence Foundation Symposium: Global Frontiers in Vaccine Development, Sanford Health and University of South Dakota, Sioux Falls and Vermillion, SD. (October 7, 2011)
  • Huber, Victor. Preventing influenza virus:bacteria super-infections through vaccination. Presented at the John H. and Amy Bowles Lawrence Foundation Symposium: Global Frontiers in Vaccine Development, Sanford Health and University of South Dakota, Sioux Falls and Vermillion, SD. (October 7, 2011)
  • McCormick, Kara, Sandbulte, Heather, Huber, Victor. Generation of a swine influenza reverse genetics system. Presented at the Eleventh Annual Symposium in Virology, Lincoln, NE. (September 30, 2011)
  • Sandbulte, Heather, Schuneman, Margaret, Juber, Brian, Addengast, Leslie, DePaula, Frank, Schlenker, Evelyn, Chaussee, Michael, Huber, Victor. Vaccination to prevent influenza virus:group A streptococcus super-infections. Presented at the Eleventh Annual Symposium in Virology, Lincoln, NE. (September 30, 2011)
  • Sun, Zhi, Huber, Victor, McCormick, Kara, Kaushik, Radhey, Fang, Ying. Characterization of a porcine intestinal epithelal cell line for influenza virus production. Presented at the American Society for Virology 30th Annual Meeting, Minneapolis, MN. (July 16, 2011)
  • Huber, Victor. Preventing influenza virus:bacteria super-infections through vaccination.
  • Huber, Victor. Preventing influenza virus:bacteria super-infections through vaccination.
  • Huber, Victor. Preventing influenza virus:bacteria super-infections through vaccination.
  • Huber, Victor. Preventing influenza virus:bacteria super-infections through vaccination.
  • Sandbulte, Heather, Schuneman, Margaret, DePaula, Frank, Addengast, Leslie, Schlenker, Evelyn, Chaussee, Michael, Huber, Victor. Contribution of inactivated influenza virus (IIV) and live, attenuated influenza virus (LAIV) vaccine-induced immunity toward limiting influenza virus:GAS super-infections. Presented at the International Conference on Gram Positive Pathogens, Omaha, NE. (October 10, 2010)
  • Cwach, Kevin, Huber, Victor. Contribution of alpha2-macroglobulin (A2-M) toward neutralization of influenza virus isolates of the H3N2 subtype. Presented at the Options for the Control of Influenza VII, Hong Kong. (September 2, 2010)
  • Sandbulte, Heather, Schuneman, Margaret, DePaula, Frank, Addengast, Leslie, Schlenker, Evelyn, Chaussee, Michael, Huber, Victor. Contribution of inactivated influenza virus (IIV) and live, attenuated influenza virus (LAIV) vaccine-induced immunity toward limiting influenza virus:GAS super-infections. Presented at the Options for the Control of Influenza VII, Hong Kong. (September 2, 2010)
  • DePaula, Frank P., Huber, Victor, Chaussee, Michael S., Schlenker, Evelyn H.. Histopathology of H3N2:GAS super-infection limited by vaccine-induced immunities (IIV, LAIV).. Presented at the Undergraduate Research Poster Presentation , Vermillion, SD. (July 26, 2010)
  • Schuneman, Margaret J., Huber, Victor. Contribution of inactivated influenza virus (IIV) and live, attenuated influenza virus (LAIV) vaccine-induced immunity toward limiting influenza:GAS super-infections. Presented at the USD Undergraduate Research Poster Presentation , Vermillion, SD. (July 26, 2010)
  • Cwach, Kevin, Sandbulte, Heather R., Addengast, Leslie A., Huber, Victor. Inhibition of influenza virus of the H3N2 subtype by innate serum inhibitors. Presented at the USD Undergraduate Research Poster Presentation, Vermillion, SD. (July 26, 2010)
  • Xiang, Xiaoxiao, Wang, Dan, Wang, Xiuqing, Li, Feng, Huber, Victor. Functional roles of C-terminal region of influenza A virus matrix protein in viral replication. Presented at the American Society for Virology 29th Annual Meeting, Bozeman, MT. (July 17, 2010)
  • Huber, Victor. Preventing influenza virus:bacteria super-infections through vaccination. Presented at the WIP Face to Face Meeting, Nebraska City, NE. (July 8, 2010)
  • Huber, Victor. Preventing influenza virus:bacteria super-infections through vaccination. Presented at the Sanford Research-USD Syposium, Vermillion, SD. (May 14, 2010)
  • Carrington, Joseph, Cwach, Kevin, Huber, Victor. Revisiting the contribution of alpha2-macroglobulin as a non-specific inhibitor of the hemagglutinin inhibition assay. Presented at the Immune Correlates of Protection Against Influenza: Challenges for Licensure of Seasonal and Pandemic Influenza Vaccines, Miami, FL. (March 1, 2010)
  • Halasa, Natasha, Englund, Janet, Nachman, Sharon, Weinberg, Geoffrey, Huber, Victor, Allison, Kim, Yi, Tingting, McCullers, Jonathan, Flynn, Pat. Safety of Live Attenuated Influenza Vaccine in Mild to Moderately Immunocompromised Children with Cancer. Presented at the 50th Annual Meeting of the European Society for Paediatric Research, Hamburg, Germany. (October 2009)
  • Huber, Victor. "Multi-valent Vaccine Strategies to Elicit Broad Immunity Within an Influenza A Subtype (H3).". Presented at the Great Plains Infectious Disease New Investigator Mee, Kansas City, MO. (September 12, 2009)
  • Halasa, Natasha, Englund, Janet, Nachman, Sharon, Weinberg, Geoffrey, Huber, Victor, Allison, Kim, Yi, Tingting, McCullers, Jonathan, Flynn, Pat. Safety of Live Attenuated Influenza Vaccine in Mild to Moderately Immunocompromised Children with Cancer. Presented at the Pediatric Academic Society , Baltimore, MD. (May 2009)
  • Huber, Victor. "What is Pandemic H1N1 Virus Teaching Us?". Presented at the Sigma Xi Science Cafe, Vermillion. (2009)